In the past year, there’s been a significant surge in interest in medication abortion via telehealth, after the Supreme Court overturned Roe v. Wade and the Food and Drug Administration made it possible for patients to get a prescription online and have the drug delivered to their front doors.
Now, telemedicine patients will have more pathways to care. A finalized rule from the FDA makes permanent the ability to distribute the medication by mail, while newly allowing retail pharmacies to distribute mifepristone, one of two drugs used to safely end an early pregnancy.
Several telemedicine companies that provide medication abortion expressed enthusiasm for opening up local pickup for patients — an option that could increase access for those who live in states where abortion is not currently legal.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect